Regenerating hepatocytes reactivate neonatal gene expression patterns. To study transcriptome changes in regenerating hepatocytes, we used a toxin-induced liver injury model 17 . Adult mice were fed a 0.1% 3,5-diethoxycarbonyl-1,4-dihydrocollidine (DDC)supplemented diet for 4 weeks followed by whole liver tissue collection for histological analysis and hepatocyte isolation for RNA sequencing (RNA-seq) ( Fig. 1a ). Gross morphology of injured livers exhibited the expected pathology 18 , including enlarged liver size, change in color from pale to dark red, and elevated serum alanine aminotransferase (ALT) and aspartate aminotransferase (AST) levels ( Fig. 1a and Supplementary Fig. 1a,b ). Additional characteristic features of DDC injury such as the presence of porphyrin plugs, hepatic necrosis, cholestasis, inflammation, and ductal hyperplasia During liver regeneration, most new hepatocytes arise via self-duplication; yet, the underlying mechanisms that drive hepatocyte proliferation following injury remain poorly defined. By combining high-resolution transcriptome and polysome profiling of hepatocytes purified from quiescent and toxin-injured mouse livers, we uncover pervasive alterations in messenger RNA translation of metabolic and RNA-processing factors, which modulate the protein levels of a set of splicing regulators. Specifically, downregulation of the splicing regulator ESRP2 activates a neonatal alternative splicing program that rewires the Hippo signaling pathway in regenerating hepatocytes. We show that production of neonatal splice isoforms attenuates Hippo signaling, enables greater transcriptional activation of downstream target genes, and facilitates liver regeneration. We further demonstrate that ESRP2 deletion in mice causes excessive hepatocyte proliferation upon injury, whereas forced expression of ESRP2 inhibits proliferation by suppressing the expression of neonatal Hippo pathway isoforms. Thus, our findings reveal an alternative splicing axis that supports regeneration following chronic liver injury. NAtuRE StRuCtuRAl & MolECulAR Biology | VOL 25 | OCTOBER 2018 | 928-939 | www.nature.com/nsmb
T he mammalian liver possesses remarkable ability to regenerate after injury with the potential to restore up to 70% of its lost mass and function in just a few weeks 1, 2 . Under normal circumstances, the liver sustains the turnover of its fully differentiated parenchymal cells-hepatocytes and cholangiocytes-through self-duplication 3, 4 . Furthermore, upon acute injury such as partial hepatectomy, residual mature hepatocytes undergo hypertrophy or re-enter the cell cycle to proliferate and restore liver functionality 5 . Yet, if the liver is severely damaged and hepatocyte proliferation compromised by certain drugs or toxins, other cells, such as the bipotential hepatobilliary progenitors, may contribute towards regeneration by giving rise to new hepatocytes [6] [7] [8] . These progenitor cells are thought to serve as facultative stem cells that can differentiate into hepatocytes or cholangiocytes during chronic injury conditions 9 . Recent cell-fate and lineage-tracing studies, however, found no evidence for existence of such facultative stem cells in mouse livers, and demonstrated that, under both acute and chronic injury conditions, virtually all new hepatocytes are derived from pre-existing hepatocytes [10] [11] [12] [13] [14] [15] [16] . These findings indicate that adult hepatocytes can proliferate even after severe liver damage, but the core mechanisms that trigger a quiescent hepatocyte to re-enter the cell cycle remain elusive.
Here, we sought to determine how hepatic gene expression programs are remodeled following injury to support proliferation while maintaining essential liver functions, and which factor(s) regulate these remodeling events. We developed a cell type-specific polyribosome-profiling method and combined it with deep transcriptome analyses to probe messenger RNA translation at a genome-wide scale. Comparing ribosome occupancies of hepatocyte mRNAs from naïve and toxin-injured adult mouse livers revealed global translation reprogramming in regenerating hepatocytes, which mimicked a neonatal-like gene expression program. We found that downregulation of Epithelial Splicing Regulatory Protein 2 (ESRP2) is essential for reactivating the neonatal splicing program for a large set of mRNAs associated with cell proliferation, including the Hippo signaling pathway. We also demonstrated that deletion of ESRP2 in mouse livers results in excessive hepatocyte proliferation upon injury, whereas maintaining high ESRP2 expression during toxin exposure blocks proliferation by inhibiting the adult-to-neonatal switch in splicing of core Hippo pathway genes. Thus, our results identify remodeling of mRNA splicing and translation as part of the molecular network that controls hepatocellular plasticity during regeneration and provide direct evidence that alternative splicing modulates Hippo signaling to tune hepatocyte proliferation in response to chronic liver injury.
were also observed ( Supplementary Fig. 1c ). Furthermore, we detected a substantial increase in hepatocyte proliferation indicated by both 5-ethynyl-2'-deoxyuridine (EdU) labeling of new DNA synthesis and immunostaining using hepatocyte nuclear factor 4-alpha (Hnf4α ) and phospho-histone-3 (PH3) (Fig. 1b,c and Supplementary Fig. 1c ).
Hepatocytes were isolated from CHOW-fed or DDC-injured adult livers and their relative purity determined by robust de-enrich-ment of non-parenchymal cell markers and a reciprocal enrichment of adult hepatocyte markers ( Fig. 1d and Supplementary Fig. 1d ). Because the hepatic transcriptome is extensively remodeled during postnatal liver maturation 19 , we hypothesized that in order to proliferate a mature hepatocyte might utilize similar gene expression programs that are active in a neonatal hepatocyte. So, we isolated hepatocytes from embryonic day 18 (E18) livers in parallel ( Supplementary Fig. 1e ) and performed RNA-seq on poly(A)-selected RNA from all three sample groups (E18, adult CHOW-fed, adult DDC-fed). Excellent mapping rates and reproducibility between biological replicates were achieved (Supplementary Table 1 and Supplementary Fig. 1f -h).
Injury-induced liver regeneration affected the mRNA abundance of approximately 21% of genes expressed in hepatocytes (> 1 transcript per million (TPM)), as we identified 1,214 upregulated and 927 downregulated mRNAs (fold change > 2.0, false discovery rate (FDR) < 0.05) between quiescent and toxin-injured hepatocytes (Fig. 1e ). Comparative analysis of the developmental [E18 (CHOW)-Adult (CHOW)] and regenerative [Adult (CHOW)-Adult (DDC)] transcriptomes revealed that nearly 76% of differentially expressed mRNAs in regeneration (1,631 of 2,141) revert their expression pattern towards the neonatal stage (Fig. 1f ). The other 24% of mRNAs (510 of 2,141) changed exclusively in regenerating hepatocytes, as their abundance was unaltered through liver development ( Fig. 1g) . A large but separate cohort of developmentally regulated mRNAs, however, showed only a modest adult-to-neonatal shift in expression upon injury ( Fig. 1h ). Thus, our global analysis revealed portions of the hepatocyte transcriptome that undergo dampening of the adult, or reactivation of the neonatal, gene expression program in response to injury ( Supplementary Fig. 2a ). Further, we noted that the transcripts exhibiting decreased expression upon injury form highly connected gene networks of biological functions associated with mature hepatocytes, such as metabolic and biosynthetic processes ( Supplementary Fig. 2b,c) . In contrast, the transcripts exhibiting increased mRNA expression clustered into the cell cycle and growth factor signaling categories. Interestingly, while the development-specific group was similarly enriched for metabolic and cell cycle-related genes ( Supplementary Fig. 2b,e ), the regeneration-specific group formed uniquely enriched clusters of mRNAs involved in immune or endoplasmic reticulum stress response, cell proliferation, and regulation of mRNA translation ( Supplementary  Fig. 2d ). Overall, these results illustrate that, in response to injury, mature hepatocytes selectively reprogram a portion of their transcriptome to a less differentiated, 'neonatal-like' state.
Reprogramming of mRNA translation in regenerating hepatocytes. Because the mRNA translation process was enriched within the 'regeneration-specific' gene cluster ( Supplementary Fig. 2d ), we hypothesized that, in addition to the transcriptome, hepatocytes may also reprogram their translatome following injury. We systematically probed the translation output of naïve and regenerating hepatocytes by combining cell type-specific in vivo polyribosome profiling with deep transcriptome analyses. To ensure proper isolation of intact mRNA and ribosomal complexes from hepatocytes, we first perfused the liver with cycloheximide to stall the translating ribosomes ( Supplementary Fig. 3a ). Addition of cycloheximide at the start of the isolation procedure circumvents any shifts in ribosomal occupancies due to the stress of the procedure itself, as stress responses can influence gene-specific translation within minutes 20 . RNAs cofractionating with monosomes, light polysomes (2-4 ribosomes), and heavy polysomes (> 4 ribosomes) were purified, poly(A) selected, and sequenced to obtain transcript-level abundances. For each fraction, high reproducibility between biological replicates was obtained ( Supplementary Fig. 3b -i).
To determine the changes in ribosomal occupancy of each transcript, we calculated an index we refer to as the fractional shift ratio 21 , which involved determining log 2 ratios of the fractional abundance of transcripts present between CHOW-and DDC-fed mice. This calculation was performed on all expressed transcripts from each fraction, resulting in a distribution of transcript shift ratios ( Fig. 2a-c) . A null set was generated using the control CHOW samples to allow for the determination of significant shifts in ribosome occupancy (P value < 0.01, FDR < 0.1). We identified 1,486 transcripts within 1,326 (~9%) protein-coding genes that undergo robust ribosomal occupancy shifts in regenerating hepatocytes. Specifically, 796 transcripts showed increased ribosomal occupancy (translational activation), whereas 530 transcripts showed decreased ribosomal occupancy (translational repression). Among the groups of mRNAs with increased and decreased translation, we found further subclusters. For instance, while most mRNAs increasing in ribosomal occupancy shifted from monosomes directly to heavy polysomes, there were also groups of mRNAs that shifted from monosomes to light polysomes or light to heavy polysomes and vice versa ( Fig. 2d ). Hence, we conclude that the hepatocyte translatome is extensively reprogrammed after injury and, for many mRNA transcripts, this reprogramming varies greatly in terms of magnitude and regulatory dynamics.
We next asked whether there was any overlap between gene sets shifting in ribosomal occupancy and/or mRNA abundance after injury. Only a small number of translationally regulated mRNAs showed a concurrent change in abundance, implying that these two modes of regulation occur independently in regenerating hepatocytes ( Fig. 2e ). The most significant network of translationally upregulated mRNAs belonged to 'RNA processing and translation' categories, whereas the translationally repressed genes clustered into the 'glucose and lipid metabolism'-related pathways ( Fig. 2d ). Intriguingly, these pathways are similarly enriched within gene sets that differ in mRNA abundance ( Supplementary Fig. 2b ); yet, the actual genes regulated via changes in either abundance or ribosome occupancies are mutually exclusive ( Fig. 2e ). These data, therefore, demonstrate that although the mRNA expression and translation regulatory networks appear to work independently at the individual gene level, their cumulative effects at the pathway level are synergistic during liver regeneration.
Regenerating hepatocytes alter translation of splicing factors and activate a neonatal splicing program. Transcripts coding for mRNA translation and splicing factors were enriched for ribosome occupancy shifts following injury ( Fig. 2d and Supplementary Fig. 3j ). We quantified individual transcript levels of eight developmentally regulated splicing factors in the liver 19 by quantitative (qPCR) and observed significant shifts in ribosome occupancies for seven of these eight factors (Fig. 3a ). We also examined the protein abundance of these factors by western blots in hepatocytes and detected substantial changes in their steady-state levels (Fig. 3b ). Thus, the mRNAs encoding splicing factors, which differed significantly in their ribosome occupancies upon toxin injury, exhibited a corresponding change at the protein level, verifying that our polysome profiling method can positively predict changes in protein abundance through translational regulation.
Alternative splicing decisions are influenced by splice site strength, cis-acting regulatory elements within pre-mRNAs that promote or inhibit exon recognition, and activity of trans-acting factors that bind to these cis elements and regulate the accessibility of the spliceosome to splice sites [22] [23] [24] [25] [26] [27] . Given the notable changes in protein abundance for a number of splicing factors in regenerating hepatocytes, we further analyzed our RNA-seq data for changes in alternative splicing. We identified 420 significantly changing splicing events (difference in percent spliced index (Δ PSI) > 15%, FDR < 0.10) within 349 genes, with an expected distribution of splice event type ( Fig. 3c ) and relatively little overlap with genes regulated at the mRNA abundance levels ( Fig. 3d ). Of the regeneration-regulated events, > 80% were also regulated during development, with high similarity between the splicing patterns of neonatal and regenerating hepatocytes ( Fig. 3e,f) . Moreover, these alternatively spliced transcripts were enriched in functions such as chromatin modification and regulation of transcription and splicing ( Fig. 3g ). Collectively, our data suggest that, following injury, hepatocytes redeploy a neonatal splicing program by modulating the protein abundance of key splicing factors through translational reprogramming.
mRNA and protein features of regeneration-regulated exons.
Global interactome studies have shown that alternatively spliced isoforms tend to generate distinct proteins rather than minor variants of each other 28 , and these isoforms can be further post-translationally modified to produce even more diverse proteomes [29] [30] [31] . To explore the functional impact of programmed changes in splicing, we first investigated the spatial distribution of regeneration-regulated exons along their associated transcripts. Of the alternatively spliced events detected from our analysis, 95% (399 of 420) occurred in protein-coding genes. Furthermore, 70% of differentially spliced exons were located within coding sequences (CDSs) and a significant number of those (24%) encoded an alternate START or STOP codon (Fig. 4a ). The CDS-mapped exons were further separated based on whether they were open reading frame (ORF) preserving (exon length is a multiple of three) or non-preserving. We found that the majority (~64%) of CDS events preserve the ORF, thus adding or removing a peptide segment in the protein. Intriguingly, only 11 of the 66 (~17%) ORF non-preserving regions present within the CDS were predicted to be nonsense mediated decay targets ( Fig. 4a ). These results suggest that a number of regeneration-regulated exons may be altering the intrinsic features of respective proteins.
Next, we selected regeneration-regulated cassette exons that had at least 80% sequence conservation between mice and humans (n = 220) and probed their functional properties. Our analysis revealed many distinct protein features encoded by these exons, including structural and binding elements, cellular localization, and post-translational modifications (Fig. 4b ). Within the localization category, a significant number of exons (n = 52) contain nuclear export and membrane localization signals, suggesting that programmed changes in splicing after injury may be a common mechanism to regulate subcellular targeting of proteins ( Fig. 4c ). Amid different domains, 'protein-binding' segments predominated within the regeneration-regulated exons ( Fig. 4d ) and, when compared with randomized sets of constitutive or non-regulated alternative exons, the regulated exons were significantly enriched for intrinsically unstructured regions ( Fig. 4e ). We further noted that these unstructured regions were enriched for phosphorylation compared to other post-translational modification sites, and they frequently encoded conserved serine/threonine but not tyrosine residues ( Fig. 4e ). Altogether, these results suggest that through alternative inclusion of peptide segments-which contain proteinbinding domains or disordered binding motifs with phosphosites-the regenerating hepatocytes may effectively rewire their protein-protein interactions.
ESRP2 downregulation following injury supports hepatocyte proliferation. Our next goal was to identify the regulatory factor(s) responsible for reactivating the neonatal splicing program and test whether they serve any direct roles in liver regeneration. Amongst the various splicing factors that differed in expression after DDC injury ( Fig. 3a, b) , we elected to focus on ESRP2 because: (1) ESRP2binding motifs were highly enriched around regeneration-regulated exons, and (2) ESRP2 is a key hepatocyte factor that controls ~20% of splice isoform transitions occurring naturally during postnatal liver development 19 . To determine whether injury-induced ESRP2 downregulation is reversible, we administered DDC diet to wildtype (WT) mice for four weeks (injury phase) and then switched them to regular CHOW diet for the next four weeks (recovery phase) ( Fig. 5a ). As expected, the characteristic hepatocellular damage and regeneration response abated considerably when the animals were recovered ( Supplementary Fig. 4a-d ). Notably, ESRP2 displayed a dynamic expression pattern during the injury and recovery phases of liver regeneration. ESRP2 protein levels decreased considerably when mice were fed DDC diet but were fully restored upon toxin removal ( Fig. 5b) . Also, the downregulation occurred relatively early as ESRP2 protein levels started to decline within 5 days of DDC administration ( Supplementary Fig. 4e ).
To evaluate the physiological relevance of ESRP2 downregulation in liver regeneration, we used Esrp2 knockout mice. The mice lacking ESRP2 have relatively normal growth and are fertile, but their hepatocytes are immature, smaller in size, and a significant number fail to fully exit the cell cycle 19 . Adult littermates of WT and Esrp2 knockout mice were subjected to the same DDC injury-recovery protocol ( Fig. 5a ). While the liver damage (necrosis, inflammation, and presence of porphyrin plugs) and systemic symptoms (weight loss and jaundice) after DDC treatment were comparable between WT and Esrp2 knockouts ( Fig. 5c , top row), the hepatosomatic index (liver/body weight ratio) of the knockouts was substantially higher under both injury and recovery conditions ( Fig. 5d ). We reasoned that higher hepatosomatic index in the absence of ESRP2 might be due to excessive hepatocyte proliferation during the injury-recovery circumstances. We quantified the number of proliferating hepatocytes by co-immunostaining the DDC-injured and recovered liver sections from WT and Esrp2 knockouts with the mitotic marker PH3 and the hepatocyte marker Hnf4α . We detected significantly more PH3 + proliferating cells among Hnf4α + cells in Esrp2 knockouts compared to WT mice under both injury and recovery conditions ( Fig. 5c , middle row, and 5e). Quantification of the ductular reaction (KRT19 + cholangiocytes) throughout the injury-recovery circumstances, however, showed no difference between WT and Esrp2 knockout livers (Fig. 5c , bottom row, and 5f).
To further investigate whether ESRP2 downregulation is required for hepatocyte proliferation, we generated tetracyclineinducible, hepatocyte-specific FLAG-tagged ESRP2 transgenic mice ( Supplementary Fig. 5a ). As anticipated, the TRE-ESRP2 (TRE, tetracycline response element); ApoE-rtTA bitransgenics, hereafter referred to as ESRP2 overexpression (ESRP2 OE) mice, allowed conditional, doxycycline (Dox)-dependent expression of ESRP2 ( Supplementary Fig. 5b ). We titrated the dose of Dox needed in the diet to restore ESRP2 protein expression in DDC-injured livers ( Supplementary Fig. 5c,d ). Remarkably, sustaining higher ESRP2 protein levels inhibited the increase in liver mass typically observed in response to DDC injury ( Fig. 5d ). Consistent with this observation, we witnessed a significant block in hepatocyte proliferation as revealed by the reduced number of PH3 + and Hnf4α + cells in ESRP2 OE mouse livers following injury when compared to uninduced littermate controls ( Fig. 5c , middle row, and 5e). Maintaining high ESRP2 protein levels, however, had little effect on overall ductal hyperplasia (Fig. 5c , bottom row, and 5f). Next, we performed serum biochemical tests to measure the extent of liver function and hepatocellular damage in DDC-fed control and ESRP2 OE mice. Both total and direct serum bilirubin and ALT levels were significantly elevated in ESRP2 OE mice when compared with littermate controls (Fig. 5g,h) , indicating that impaired hepatocyte proliferation following injury compromises their liver function. Collectively, these data provide compelling evidence that downregulation of ESRP2 supports the proliferative capacity of hepatocytes in response to chronic liver injury.
ESRP2 downregulation generates neonatal isoforms of Hippo pathway proteins. We next examined whether ESRP-binding motifs are overrepresented near alternative exons that undergo a robust change in splicing upon liver injury. We found that UGGrich ESRP2 motifs 32 , UGGUG and UUGGG, are significantly enriched (blue line) in the upstream introns of exons that exhibit enhanced inclusion in response to DDC injury (Fig. 6a ). The ESRP motif UUGGG was also enriched in the downstream introns of exons (red line) that are repressed upon injury (Fig. 6a ). These observations corroborate with ESRP2 downregulation in regenerating hepatocytes and the typical ESRP RNA map where the upstream binding represses and the downstream binding promotes alternative exon inclusion 33, 34 .
To assess the functional impact of ESRP2 downregulation in reprogramming alternative splicing, we used PCR with reverse transcription (RT-PCR) to screen the top 25 ESRP2-sensitive exonsobtained from ref. 19 -in the livers of Esrp2 knockout, ESRP2 OE, and littermate control mice fed either CHOW or DDC diet. These exons showed a reciprocal switch in splicing in Esrp2 knockout and ESRP2 OE when compared with WT mice (Fig. 6b ). The gel images of RT-PCR products from two representative examples-Arhgef10l 15-nucleotide (nt) exon and Lsm14b 78-nt exon-are shown in Supplementary Fig. 6a . Consistent with reduced ESRP2 protein expression following injury, all splicing events in the DDC-fed WT and CHOW-fed Esrp2 knockout mice were highly correlated in both pattern and directionality. Strikingly, sustaining ESRP2 protein levels blocked the injury-induced shift in splicing, indicating that ESRP2 downregulation is key for stimulating these splicing transitions ( Fig. 6b and Supplementary Fig. 6a ).
Among ESRP2 splicing targets, we found several genes involved in cell proliferation, including core components of the Hippo signaling pathway such as Neurofibromatosis 2 (Nf2), Casein kinase 1 delta (Csnk1d), Yes-associated protein 1 (Yap1), and Tea domain transcription factor 1 (Tead1) (Fig. 6b ). Hippo signaling is a conserved pathway that governs organ size, tissue homeostasis, and regeneration in metazoans, and its deregulation results in uncontrolled cell proliferation and malignant transformation [35] [36] [37] . Furthermore, Hippo signaling is required for maintaining the differentiated state of hepatocytes and serves essential roles for cell fate determination in normal and regenerating livers [38] [39] [40] [41] .
When Hippo signaling is on, NF2 acts as an upstream activator of the MST1/2-WW45 complex, which phosphorylates and activates LATS1/2 kinases ( Supplementary Fig. 6b ). Activated LATS1/2 phosphorylate YAP1 to sequester it in the cytoplasm by 14-3-3 proteins, or prime it for additional phosphorylation by CSNK1D, which promotes β -TrCP-mediated degradation of YAP1. Upon inactivation of Hippo signaling, YAP1 accumulates in the nucleus and partners with the TEAD family of transcriptional factors, stimulating expression of pro-proliferative genes. Interestingly, Nf2, Csnk1d, Yap1, and Tead1 each encode a conserved developmentally regulated exon that is predominantly skipped in neonatal but included in the adult hepatocytes ( Fig. 6c ). We found that ESRP2 coordinates the postnatal inclusion of these in-frame exons to generate adult protein isoforms. ESRP2 deletion promoted their skipping and, therefore, production of neonatal isoforms in the adult liver, whereas ESRP2 OE enhanced the production of adult isoforms ( Fig. 6d and Supplementary Fig. 6c ). The presence of nearby ESRP2 binding sites along with skipping of all four exons following transient depletion of ESRP2 in cultured hepatocytes further confirmed ESRP2 as their primary regulator ( Supplementary Fig. 6d-f ). Importantly, similar to Esrp2 knockouts, DDC-injury in WT mice evoked an adult-to-neonatal shift in splicing, whereas sustaining ESRP2 expression during injury preserved the adult splicing pattern for all four genes ( Fig. 6d and Supplementary Fig. 6c ). As was previously reported [42] [43] [44] , liver injury inhibited the Hippo pathway and upregulated the expression of its gene targets (Fig. 6e) . Notably, the injury-induced upregulation of target genes was considerably higher in Esrp2 knockouts, but was largely blunted in ESRP2 OE (Fig. 6e ). Together, these data reveal that ESRP2 downregulation following injury reprograms the splicing of core Hippo pathway components, probably modulating their signaling and downstream gene expression activity.
Neonatal isoforms attenuate Hippo signaling and promote hepatocyte proliferation. We next explored the functional differences between neonatal and adult protein isoforms of NF2, CSNK1D, YAP1, and TEAD1. The neonatal NF2 protein isoform exists in two functionally distinct conformations 45, 46 . In the open and active form, the LATS1/2 binding site is freely accessible, and thus Hippo signaling is enabled (Fig. 7a, panel 1 ). In the closed and inactive form, the C-terminal domain (CTD) binds to the N-terminal FERM domain and blocks access to the LATS1/2 binding site, thereby inhibiting Hippo signaling. The adult NF2 protein isoform, however, includes a 45-nt exon at the end of the CTD, which encodes an early STOP codon resulting in truncation of 5 amino acid residues, 4 of which are necessary for FERM binding (Fig. 7a, panel 1) . The alternative exon also alters the composition of 11 other amino acids from primarily hydrophobic to charged residues, which are expected to create a repulsive force between the CTD and the hydrophobic binding pockets in the FERM domain 46 . Thus, the adult NF2 isoform probably adopts a constitutively open state providing uninterrupted access to LATS1/2, thereby promoting YAP phosphorylation and degradation.
The neonatal CSNK1D protein isoform encodes a C-terminal tail containing a stretch of serine residues (Fig. 7a, panel 2) , which when phosphorylated lower its enzymatic activity 47 . Elimination of these auto-inhibitory phosphorylation sites through truncation or site-directed mutagenesis enhances the CSNK1D kinase activity towards its substrates [47] [48] [49] . The adult CSNK1D protein isoform includes a 63-nt exon in the C-terminal tail, which, like NF2, encodes an early STOP codon truncating 6 amino acid residues (Fig. 7a, panel 2) . Notably, this eliminates three serine residues in the adult CSNK1D isoform, which should relieve the auto-inhibition and thus generate a more active kinase for YAP phosphorylation and degradation.
YAP1 encodes a leucine zipper within its transcription activation domain that is important for protein-protein interactions. The neonatal YAP1 isoform has an intact leucine zipper with 4 heptads; however, the inclusion of a 48-nt exon in the adult YAP1 isoform inserts a 16-amino-acid-long intrinsically unstructured segment between heptad H3 and H4, leading to its thermodynamic destabilization (Fig. 7a, panel 3) . Consequently, the inability of the adult YAP1 protein isoform to form a functional leucine zipper is expected to hinder the protein-protein interactions needed for its hetero-association with other cellular partners [50] [51] [52] .
TEAD proteins share a highly conserved N-terminal TEA domain that binds to DNA and a C-terminal transactivation domain, which binds the cofactor YAP1 to induce target gene expression 53 . The TEA domain is composed of a three-helix bundle, where the H3 helix provides the interface for DNA binding 54 . The 12-nt microexon in the adult TEAD1 protein isoform adds 4 amino acids just downstream of the DNA binding helix H3 (Fig. 7a, panel 4 ). Amongst these four amino acids is a conserved serine residue, which when phosphorylated by protein kinase A or C strongly inhibits TEAD1's DNA-binding ability 55, 56 . Thus, inclusion of this microexon should serve as an alternate mechanism for reducing TEAD1 activity independent of its interaction with co-activators such as YAP1. Taken together, the developmentally regulated exons introduce functionally relevant protein segments in NF2, CSNK1D, YAP1, and TEAD1 that appear to enhance Hippo signaling and thereby allow adult hepatocytes to enter quiescence. Given that ESRP2 promotes the inclusion of these alternative exons, we reasoned that ESRP2's influence on hepatocyte proliferation upon injury might be driven in part by the production of neonatal isoforms of the Hippo signaling pathway. We therefore decided to simultaneously redirect splicing of all four exons in AML12 cells ( Supplementary Fig. 7a ), a non-transformed mouse cell line that exhibits differentiated hepatocyte features and expresses high levels of hepatic mRNAs 57 . Serum starvation-induced quiescence in AML12 cells led to high inclusion of Nf2 and Tead1 alternative exons and moderate inclusion of Csnk1d and Yap1 alternative exons. This observation allowed us to gauge the combined effect of these exons on Hippo signaling and proliferative capacity of cultured hepatocytes. Compared to control antisense morpholino oligonucleotides (ASOs), AML12 cells treated with a mixture of Nf2-, Csnk1d-, Yap1-, and Tead1-targeted ASOs elicited a near-complete switch to the exon-skipped neonatal isoforms (Fig. 7b ). Three non-targeted alternative exons were tested as control and all were unaffected, demonstrating absence of non-specific effects ( Supplementary Fig. 7b ). Also, the steady-state mRNA levels of Nf2, Csnk1d, Yap1, and Tead1 were unaltered after ASO treatment, confirming that the switch in splicing occurred without a change in total mRNA levels ( Supplementary Fig. 7c ).
To determine whether redirection of splicing affected the output of the Hippo signaling pathway, we first evaluated the phosphorylation status of key serine/threonine residues within mouse MST1/2 (T183/T180), LATS1 (S958), and YAP1 (S112) that are known to restrict YAP/TEAD-mediated gene transcription 58 . Consistent with our hypothesis, selective expression of neonatal splice isoforms led to a significant decrease in the ratio of pLATS1/LATS1 and pYAP1/YAP1 but not pMST/MST proteins (Fig. 7c ). Next, we transfected the control-and ASO mix-treated AML12 cells with a H2afy_9
Bag6_108 Yap1_48 0 -1 -0 . luciferase reporter construct containing TEAD binding sites 59 (Fig.  7d, top) . The luciferase activity from the TEAD reporter was significantly higher in AML12 cells expressing the neonatal isoforms (Fig. 7d, bottom) . Furthermore, compared with control, chromatin immunoprecipitation (ChIP) analysis from ASO mix-treated cells showed increased TEAD1 association with its response element on the target Birc5 promoter but not with the non-target Hnf4α promoter ( Supplementary Fig. 7d ). Additionally, we noted that, when neonatal isoforms were predominantly expressed, Hippo target genes showed an increase in their endogenous expression ( Fig. 7e) . We next evaluated the functionality of splicing redirection on cellular proliferation. Serum-starved AML12 cells treated with either control or the ASO mix were released in minimal serum (0.5-1%) for 24 h, followed by a 2-hr pulse with EdU. Remarkably, exclusive production of the neonatal isoforms resulted in markedly higher EdU incorporation (Fig. 7f,g) , and this enhancement of proliferation was further confirmed by MTT (3-(4,5-dimethylthiazol-2-yl)-2,5-diphenyltetrazolium bromide) assays (Fig. 7h) . Importantly, the enhanced proliferation following splicing redirection was completely abolished in YAP1-depleted cells ( Supplementary Fig.  7e,f) . Collectively, these data illustrate that production of neonatal isoforms abates Hippo signaling, which enables greater transcriptional activation of YAP1/TEAD1 target genes promoting hepatocyte proliferation.
Discussion
How changes in the transcriptome and/or translatome influence the proliferative capacity of hepatocytes following injury and how post-transcriptional gene regulatory mechanisms integrate into these paradigms are still unresolved questions. In this study, we uncovered that dynamic remodeling of mRNA splicing and translation programs is critical for hepatocyte proliferation in response to chronic liver injury. Our work further revealed that dynamic regulation of ESRP2 coordinates the adult-to-neonatal splicing switch of many proliferation-related genes, including core components of the Hippo signaling pathway, which may constitute a fundamental mechanism used by hepatocytes to adapt to injury. Importantly, we identified that ESRP2 controls the splicing of developmentally regulated exons in NF2, CSNK1D, YAP1, and TEAD1 to introduce functionally relevant protein segments that enhance Hippo signaling. We found that, in comparison to the adult, the neonatal Hippo splice isoforms have innately lower signaling capacity, which allows higher transcriptional activity of the downstream YAP1 and TEAD1 effectors, thereby sustaining hepatocyte proliferation during the fetal and early postnatal periods of development. After birth, ESRP2 protein levels rise in hepatocytes 19 to promote the generation of adult isoforms of Hippo pathway that favor quiescence. We also showed that, following injury, ESRP2 downregulation reactivates a neonatal splicing program to rewire the Hippo signaling pathway and enable quiescent hepatocytes to proliferate. Accordingly, we demonstrated that Esrp2 knockout mice manifest excessive hepatocyte proliferation after injury, whereas sustaining high ESRP2 expression during toxin exposure inhibits hepatocyte proliferation by impeding the formation of neonatal splice isoforms of the Hippo signaling pathway. In the future, it will be important to develop isoform-specific antibodies and/or mass spectrometry-based methods to generate reliable, quantitative measurements of alternatively spliced Hippo pathway proteoforms and further interrogate their biological significance.
In conclusion, we have identified a novel ESRP2-Hippo pathway alternative splicing axis that tunes hepatocyte proliferation and facilitates regeneration in response to chronic liver injury. It remains to be seen whether this axis is also utilized to regenerate after acute liver injuries such as partial hepatectomy, and whether this axis can be therapeutically harnessed to stimulate regeneration during acute liver failure or end-stage liver disease.
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Methods
Animal models. National Institutes of Health (NIH) and institutional guidelines were followed in the use and care of laboratory animals and experimental protocols were performed as approved by the Institutional Animal Care and Use Committee at University of Illinois, Urbana-Champaign (UIUC). Animals used in the study were identified using ear tags after being genotyped at weaning age. The following study is not gender-specific and specimens include both male and female animals. Whole liver tissues and hepatocytes were isolated from mice following guidelines for euthanization and/or anesthesia.
FVB/NJ mouse strain was used primarily for all experiments including RNAseq, RNA isolation, histology, western blotting, and polysome profiling. For ESRP2 loss-of-function studies, ESRP2 (− /− ) and ESRP2 (+ /+ ) animals with a C57BL/6J background were used as described previously 19, 33 . For gain-of-function studies, mouse ESRP2 complementary DNA containing an N-terminal 1× FLAG-tag was expressed from a transgene with a TRE/minimal cytomegalovirus (CMV) promoter, Esrp2 ORF, and Bovine growth hormone polyadenylation site, and 3' flanking genomic segment for mRNA 3' end formation. The linearized transgene construct was subjected to pronuclear injection using standard methods to generate TRE-Esrp2 transgenic mice that were maintained on a C57BL/6J background. ApoE-rtTA transgenic mice expressing an rtTA variant specifically in hepatocytes were obtained courtesy of Dr. D. Pan (University of Texas Southwestern Medical Center) 60 . All mice reported in this study were the F1 progeny of TRE-Esrp2 and ApoE-rtTA transgenic mice mating, and always hemizygous for both transgenes.
Murine diet scheme.
For toxin-mediated liver injury, the FVB/NJ strain of mice at 8-10 weeks of age was used. For all experiments the mice were fed a diet containing 0.1% DDC (Teklad, Envigo) for 4 weeks, unless mentioned otherwise. Additionally, for the purposes of ESRP2 gain-of-function studies, mice were fed a mixed diet containing 0.5-2.0 g kg −1 doxycycline in addition to 0.1% DDC for 4 weeks (Teklad, Envigo).
Isolation of neonatal and adult hepatocytes.
Hepatocytes from normal and DDCfed mouse livers were isolated using adapted protocols from previously described methods 61 . Briefly, adult FVB mice were anesthetized in a chamber supplied with isoflurane and oxygen (2.5% isoflurane in oxygen, 1 l min −1 ) and maintained on the anesthetic during the procedure. The liver was perfused via cannulation of the portal vein with 50 ml Solution A (1× HBSS (without Ca 2+ and Mg 2+ ), 0.5 mM EDTA) followed by 50 ml of Solution B (1× HBSS (Hank's balanced salt solution) (with Ca 2+ ), 5.4 mM CaCl 2 , 0.04 mg ml −1 soybean trypsin inhibitor, and 4,500 units of collagenase type I (Worthington Chemicals)). Subsequently, the liver was massaged in a petridish containing 1× HBSS to release cells from the liver capsule, and then the cell suspension was passed successively through and 70-and 40-μ m filters to obtain a single-cell suspension. The cells were then centrifuged at 50 × g for 5 min (4 °C) to separate live hepatocytes from non-parenchymal cells and dead cells. The cells were further washed 3 times in 1× HBSS as above, and then flash frozen in liquid N 2 and stored at − 80 °C till further use.
RNA-seq analysis. RNA was isolated from experiment specific hepatocytes using RNeasy tissue mini-kit (Qiagen). Downstream RNA quality was assessed using an Agilent Bioanalyzer, and quantified using a Qubit Fluorometer by the Functional Genomics Core at the Roy J. Carver Biotechnology Center, UIUC. Hi-Seq libraries were prepared, and 100-bp paired-end Illumina sequencing was performed on a HiSeq 4000 at the High Throughput Sequencing and Genotyping Unit, UIUC. RNA-seq reads were processed for quality and read length filters using Trimmomatic (version 0.38) 62 . RNA-seq reads were further aligned to the mouse genome (mm10) using STAR (version 2.4.2a) 63 . Mapping percentage and sample details are provided in Supplementary Table 1 . Gene expression levels were determined as TPM using count and differential expression values obtained from DESeq2 (version 1.8.2) and HTseq (version 0.6.1) 64, 65 . Genes were considered as having significant differential expression following imposed cutoff clearance (FDR < 0.05, log 2 (fold change) > 1). Differential splicing analysis was performed using rMATS (version 3.2.5), and significant events were identified using imposed cutoffs (FDR < 0.10, junction read counts ≥ 10, PSI ≥ 15%) 66 . Motif analysis for differentially spliced exons was performed using rMAPS with default parameters, and putative motifs as described previously 19, 67 . Gene ontology analysis was performed using DAVID (version 6.8) 68 , and mapped using the 'Enrichment Maps' plugin in Cytoscape. All expressed genes with TPM > 1 served as background, and the biological function category was analyzed with three pathways (Biocarta, Kegg, and Panther). Functional clustering was performed and top clusters (P value < 0.05) represented. For grouping genes into clusters, we first overlapped the differentially expressed gene sets (FDR < 0.05, log 2 (fold change) > 1) between regeneration (Adult DDC-CHOW) and development (E18-Adult CHOW) categories. The overlapping and non-overlapping gene sets were then grouped and their corresponding average fold change relative to the E18 time point was calculated and plotted.
Custom scripts were used to perform metagene analysis to determine the spatial distribution of differentially spliced exons along their associated transcript. Specifically, genomic coordinates of the alternative and flanking exons provided by the rMATS output were utilized to map the event to all annotated transcripts in the GRCm38.p4 gene annotation GFF3 file available from GENCODE. For this analysis, of all possible annotations, the longest protein-coding mRNAs were used to calculate the spatial distribution. Depending on the type of alternative exon, further processing was performed to obtain the alternating region that varied between the exon included and excluded variants. Next, the events were separated based on the locations the alternative regions mapped to on the mRNA; CDS, 5' untranslated region and 3' untranslated region. Each of these 3 regions were scaled to an arbitrary unit of 1.0 which was then separated into 20 equal-sized bins. Next, each bin was given a count of 1 if a mapped alternative region overlapped within the bin region. Using these count values, the normalized frequency distribution was calculated and scaled with respect to the peak bin across all three mRNA regions.
Additionally, to perform the exon ontology analysis, the spliced exons regulated in regeneration obtained from the above analysis were used. The cassette/spliced exon class of these mm10 annotated mouse exons were converted to corresponding human exons in the hg19 annotation using UCSCliftover with minimum ratio of bases matching as 0.8. Additionally, the exons in hg19 reported by UCSCliftover were checked for gene identity match to the mouse exon's parent gene. These exons were then analyzed for ontology using the exon ontology and FasterDB packages 69 .
Polysome gradient fractionation. Mice on normal CHOW and 0.1% DDC diet as described before were used for polysome fractionation from hepatocytes. A modified perfusion protocol was developed wherein the animals were firstly perfused via portal vein cannulation with 75 ml Solution I (300 µ g ml −1 cycloheximide in 1× HBSS (with phenol red)) at a rate of 3.5 ml min −1 . EDTA was excluded from Solution I due to its dissociative effects on ribosomes and associated complexes. Instead, liver perfusion and hepatocyte wash buffers were supplemented with cycloheximide (300 µ g ml −1 ) to arrest translating ribosomes 70 .
Purified hepatocytes were thawed in polysome lysis buffer (10 mM Tris-HCl at pH 8.0, 150 mM NaCl, 5 mM MgCl2, 1 mg ml −1 heparin, 1% Nonidet-P40, 0.5% deoxycholate, 40 mM dithiothreitol, 1 U ml −1 SUPERaseIn RNase inhibitor (Thermo Fisher), and 150 µ g ml −1 cycloheximide) and lysed by pipetting gently 10 times. The cell nuclei and cell debris were removed by centrifugation (12,000 × g, 1 min, at 4 °C). The supernatant was transferred to a fresh tube and then centrifuged again to remove remaining cell debris and organelles (16,000 × g, 7.5 min, at 4 °C). The resulting supernatant was transferred to a fresh tube and 400 µ l supernatant was layered onto a 10-ml linear sucrose gradient (15-45% sucrose (w/v) made using a Biocomp Gradient Master) and centrifuged in an SW41Ti rotor (Beckman) for 125 min at 38,000 r.p.m. and 4 °C, as previously described 71 . Polysome profiles were recorded using a UA-6 absorbance (ISCO) detector at 254 nm and fractions were collected along the gradient corresponding to the ribonucleoparticles, monosomes, light polysomes (2-4 ribosomes), and heavy polysomes (5+ ribosomes).
RNA for downstream sequencing and validations was purified using an adapted protocol 72 . The sucrose gradient fractions were mixed with 0.05 volumes of 3 M sodium acetate and 2 μ l glycogen followed by addition of 2 volumes of 100% EtOH, and stored at − 80 °C overnight to precipitate RNA/protein. The pellet was suspended in molecular grade water and, post DNase digestion, the sample was phase separated using 3 volumes of acid phenol/chloroform (5:1). The aqueous phase was again phase separated using chloroform/isoamyl alcohol (24:1). Following this, the aqueous phase was mixed with 0.1 volumes 3 M sodium acetate and 2 μ l glycogen, and precipitated with 2.5 volumes EtOH overnight at − 80 C. The pelleted RNA was then used for downstream poly(A) + -selected deep sequencing or qPCR as previously described 71 .
Analysis of polyribosome sequencing. Reads were checked for quality using FastQC software, and biological replicates were checked for reproducibility using spearman correlation coefficients. Reads were mapped to the mm10 genome using STAR 63 . Transcript count abundances were estimated and normalized across conditions using Cuffnorm 73 , and the Cuffnorm-calculated fragments per kilobase per million (FPKM) values for individual transcripts was converted to TPM using the following 74 : Further, to calculate the shift in transcript distribution in a fraction between two conditions, a polysome shift ratio was calculated as follows for all fractions separately:
To test whether a calculated polysome shift ratio (PSR) value for a given transcript is significantly changing between conditions, a null set was generated using the sequencing data from the CHOW samples. CHOW-specific fastq sequence files were randomly partitioned into two separate and non-overlapping subsets to generate a null comparison. Transcript PSR values calculated from these partitions resulted in a normal distribution (μ ~ 0, and σ > 0). With the empirical null distribution, P values were calculated for all fraction-specific transcript PSRs using the Student's t-test (cutoff P < 0.01). Additionally, FDR values were calculated using the Benjamini-Hochberg method, and significance was deemed as FDR < 0.05. Finally, transcripts with significant PSR values, based on abovementioned cutoffs, in at least two fractions were considered to be significantly regulated. Clustering of transcripts was performed using heatmap.2 package in R, with the ward clustering method.
Histology and immunofluorescence staining. Post harvesting, tissues were fixed in 10% buffered formalin for 24 h, and then processed to be embedded in paraffin. Tissue sections (5-μ m) were cut and deparaffinized in xylene, then moved through serial alcohol (100%, 95%, 80%, 50%) washes to rehydrate. For hematoxylin and eosin staining, sections were washed in hematoxylin (2 min) and eosin (1 min) successively, coverslipped with permount medium, and imaged on a Hamamatsu Nanozoomer at the Institute for Genomic biology (IGB) core facility, UIUC. For immunofluorescent staining, deparaffinized and rehydrated sections were antigen retrieved in a slow cooker at 120 °C for 10 min. The retrieval was performed in either Tris-EDTA (pH 8.0) or citrate buffer (10 mM sodium citrate, 0.05% Tween 20, pH 6.0). The sections were then washed in buffer A (Trisbuffered saline (TBS) + 0.05% Triton X-100) and blocked (2 h) in 10% normal goat serum and 1% BSA at room temperature. The primary antibodies were applied to the sections at standardized concentrations and incubated overnight at 4 °C. Following this, the sections were washed in buffer A, and secondary fluorescent antibodies were applied for 1 h at room temperature. Lastly, ToPro nuclear stain was applied for 15 min at room temperature. The sections were then coverslipped using CC/Mount aqueous mounting media (Sigma). All sections were imaged on a Zeiss LSM 710 microscope at Institute for Genomic biology (IGB) core facility, UIUC. All antibodies used and respective dilutions are listed in Supplementary Table 2 .
To stain for nascent DNA synthesis in regenerating livers, normal CHOWand 0.1% DDC-fed mice (4-week treatment) were treated with a 4-h pulse of EdU administered intraperitoneally (100 μ g per g body weight). Mice were then killed, and livers were harvested and paraffin embedded. Sections (5 μ m) were deparaffinized and rehydrated, and then antigen retrieved in citrate buffer (10 mM sodium citrate, 0.05% Tween 20, pH 6.0). The sections were then washed in buffer A (Tris-buffered saline (TBS) + 0.05% Triton X-100), and blocked (2 h) in 10% normal goat serum and 1% BSA at room temperature. EdU-labelled DNA was stained with Alexa Fluor 488 using Click-iT EdU Alexa Fluor Kit (Thermo Fisher) as per the manufacturer's protocol. Following this, the abovementioned protocol for immunofluorescence was followed to stain for Hnf4α nuclear receptor and ToPro nuclear stain.
Protein isolation and western blot analysis. Protein isolation was performed on frozen liver tissue or isolated hepatocyte fractions using homogenization in bullet blender followed by sonication. Homogenization buffer (10 mM HEPES-KOH, pH 7.5, 0.32 M sucrose, 5 μ M MG132, 5 mM EDTA, and Pierce proteinase inhibitor tablet (1 tablet per 20 ml buffer volume)) was used to perform the abovementioned isolation. Before sonication, 20% SDS to a final concentration of 1% (v/v) was added. Protein concentration was measured using the Thermo Scientific BCA Assay Kit. Approximately 50 μ g of total protein sample was loaded onto a 10% SDS-PAGE gel, and then transferred onto a polyvinylidene difluoride membrane. Membranes were visualized for equal loading using Ponceau (PonS) staining solution (0.5% w/v PonS, 1% acetic acid). Membranes were blocked using 5% milk powder (w/v) in TBST (Tris-buffered saline, 0.1% Tween 20) for 2 h at room temperature. Blots were incubated in primary antibodies at predetermined concentrations overnight at 4 °C. Blots were washed in TBST, and then incubated in horseradish peroxidase-conjugated secondary antibodies for 1 h at room temperature. Blots were developed using Clarity Western ECL Kit (BioRad). All antibodies used and respective dilutions are listed in Supplementary Table 2 .
Gene expression and splice isoform analysis. Total RNA from mouse livers and hepatocytes was isolated using either the RNeasy Kit (Qiagen) or TRIzol reagent (Life Tech). Following DNase I treatment, 5 μ g RNA was reverse transcribed to cDNA using random hexamers and Maxima Reverse Transcriptase Kit (Thermo Scientific). The cDNA was diluted to a final concentration of 25 ng μ l −1 to be used downstream for qPCR-or RT-PCR-based alternative splicing assays as described previously 75 . Downstream analyses for PSI and log 2 (fold change) calculations were performed as described previously. All primers used for alternative splicing and qPCR are listed in Supplementary Table 3 .
Cell culture and transfections. All assays were performed in AML12 cells (mycoplasma free) obtained from and authenticated by ATCC. ASOs for alternative exons were designed and ordered from Gene Tools Inc., and ASO sequences are provided in Supplementary Table 3 . Cells were cultured in 96-and 12-well formats, and were serum starved for approximately 24 h after plating, along with morpholino treatments. Post serum starvation, cells were released in reduced serum (0.5-1% FBS) for up to 48 h. Cell proliferation assays were performed using a commercial non-radioactive MTT assay kit (Promega). To label for nascent DNA synthesis, Click-iT EdU Alexa Fluor 488 Kit (Thermo Fisher) was used, wherein cells were pulsed with 10 μ M EdU in cell culture media for 2 h. To stain for positive nuclei, a standard protocol from the manufacturer was used, followed by counterstaining with ToPro nuclear stain. For knockdown experiments, silencer select short interfering RNAs (siRNAs) against luciferase or Esrp2 (Thermo Fisher) and a pool of four siGenome siRNAs against Yap1 (Dharmacon) were purchased. Control or ASO mix-treated AML12 cells were transfected with gene-specific siRNA oligos using RNAiMax (Thermo Fisher) and, 24-48 h after transfection, cells were lysed for RNA, protein, and MTT assays.
Luciferase reporter and ChIP qPCR assays. Luciferase reporter assays were performed using TEAD reporter (8xGTIIC-luciferase, Addgene) and β -galactosidase vector constructs as described previously 75 . Briefly, AML12 cells were transfected with reporter plasmids using Mirus TransIT X2 according to the manufacturer's instructions. Twenty-four hours after transfection, cell extracts were assayed for luciferase expression using the luciferase assay kit (Promega). Relative reporter activities were calculated as luminescence units normalized for β -galactosidase expression. For ChIP experiments, the MAGnify Chromatin Immunoprecipitation System (Thermo Fisher) was used according to the manufacturer's instructions with minor modifications. AML12 cells were grown to about 50% confluency, and then serum starved for 24 h while being treated with control or Hippo-specific ASOs. The ASO-treated cells were released in 1% FBS for an additional 24 h and then fixed with 1% formaldehyde using the kit components. The cross-linking was stopped with glycine treatment at room temperature. After lysing 2,000,000-3,000,000 fixed cells, the chromatin was isolated and sheared to 300-500-bp fragments using Covaris M220 sonicator with the recommended settings (duty factor (df) 5%, 28 min, 4 °C). ChIP was performed using TEAD1 (5 mg), RNA pol. II (2 mg), and Mouse IgG (1 mg) antibodies and the coprecipitated DNA fragments were analyzed by qPCR (PerfeCTa Green SYBR FastMix, Quanta Biosciences). The antibodies and primers used are listed in Supplementary Tables 2 and 3 , respectively. Liver function tests. Whole blood from mice was collected via retro-orbital puncture in Capiject gel/clot activator tubes, centrifuged for 10 min at 1,200 × g, and then stored at − 80 °C till further analysis. The serum chemistry tests used commercial kits according to the manufacturer's instructions: ALT, AST (Infinity Kits, Thermo Scientific), and bilirubin (Sigma Aldrich).
Statistical analysis.
All quantitative experiments (qPCR, western blots, cell proliferation) have at least three independent biological repeats. The results were expressed with mean and standard deviation, unless mentioned otherwise. Differences between groups were examined for statistical significance using unpaired t-test with Welch's correction (for two groups), or one-way analysis of variance for more than two groups using the GraphPad Prism 6 Software. P value < 0.05 was deemed significant. Corresponding author(s): Auinash Kalsotra Life Sciences Reporting Summary Nature Research wishes to improve the reproducibility of the work that we publish. This form is intended for publication with all accepted life science papers and provides structure for consistency and transparency in reporting. Every life science submission will use this form; some list items might not apply to an individual manuscript, but all fields must be completed for clarity.
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Experimental design 1. Sample size
Describe how sample size was determined.
No sample sizes calculations were performed. For the mouse studies, 4-6 animals/genotype were used based on previous experience to obtain statistical significance. For deep sequencing experiments, two biological replicates were used for each conditions.
Data exclusions
Describe any data exclusions.
None of the data points were excluded from any of the analysis.
Replication
Describe the measures taken to verify the reproducibility of the experimental findings.
Cell culture experiments holding consistent results after three repetitions were considered significant. All western blots, and qPCR experiments were repeated at least three times.
Randomization
Describe how samples/organisms/participants were allocated into experimental groups.
Randomization was done manually. FVB/NJ and C57BL/6J strains of mice were obtained directly from the Jackson laboratories.
Blinding
Describe whether the investigators were blinded to group allocation during data collection and/or analysis.
Transgenic and wildtype mice were ear tagged with serial numbers, and were used to mark serum and tissue samples. Samples were only identified once the final data were acquired. Note: all in vivo studies must report how sample size was determined and whether blinding and randomization were used.
Statistical parameters
For all figures and tables that use statistical methods, confirm that the following items are present in relevant figure legends (or in the Methods section if additional space is needed).
n/a Confirmed
The exact sample size (n) for each experimental group/condition, given as a discrete number and unit of measurement (animals, litters, cultures, etc.)
A description of how samples were collected, noting whether measurements were taken from distinct samples or whether the same sample was measured repeatedly A statement indicating how many times each experiment was replicated
The statistical test(s) used and whether they are one-or two-sided Only common tests should be described solely by name; describe more complex techniques in the Methods section.
A description of any assumptions or corrections, such as an adjustment for multiple comparisons
Test values indicating whether an effect is present
Provide confidence intervals or give results of significance tests (e.g. P values) as exact values whenever appropriate and with effect sizes noted.
A clear description of statistics including central tendency (e.g. median, mean) and variation (e.g. standard deviation, interquartile range)
Clearly defined error bars in all relevant figure captions (with explicit mention of central tendency and variation)
See the web collection on statistics for biologists for further resources and guidance.
